
In the spring, we will participate in the 1st Czechoslovak Congress of Medical Genetics, which will take place from April 2–4, 2025, at the Cultural and Congress Center Elektra in the spa town of Luha...
Read moreVisit us at the 19th edition of the RANK 2025 conference, which will take place on March 19th and 20th at the Zlatá Štika Hotel in Pardubice. The conference is organized by the Czech Society of Clinic...
Read moreWe would like to invite you to the 23rd Kapras Day on the topic of "Clinical Genetics," which will take place on Wednesday, February 26, 2025, in the Congress Hall of Hotel Olšanka in Prague. We loo...
Read moreIntroduction
Cas9 (CRISPR associated protein9) is a RNA-guided DNA endonuclease enzyme associated with the CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) adaptive immunity system in Streptococcus pyogenes.The CRISPR/Cas9 system is the latest RNA-guided, endonuclease tool in genome editing which allows for very specific genomic disruption and replacement. Guided by a target-specific, single guide RNA (sgRNA), the Cas9 nuclease protein serves to unwind the genomic DNA duplex and cleave both strands upon recognition of the target sequence by the sgRNA, resulting in double-stranded breaks. The resulting double-stranded break gets repaired by the non-homologous end joining (NHEJ) pathway, leading to a disruption in the open reading frame of the targeted gene.
Description
Recombinant Cas9-NLS comprises the entire Cas9 protein sequence (1368 amino acids) fused to a proprietary nuclear localization sequence (NLS) and a 6 X His tag at the C-terminus. The protein has an apparent molecular weight of 162 kDa on SDS-PAGE.
Cas9 variants for various genome manipulations are available in 8 forms
Cas9 (WT)
Cas9 with nuclear localization signal (NLS)
Cas9 with 3 NLS (on C-terminus) for better nuclear localization
NickaseCas9 (D10A) for nicking
dCas9 (D10A/H840A) for simple binding
Hi-Fi1 Cas9 3NLS (K848A, K1003A, R1060A) and Hi-Fi2 Cas9 3NLS (N497A, R661A, Q695A, Q926A) for reducing genome
wide off-target effects
dCas9-biotinylated for immunoprecipitation
Features
Low endotoxin Level
High Biological activity
Consistent from lot to lot
Application
Genome editing
Source
Cas9 gene from Streptococcus pyogenes expressed in E. coli
Purity
Greater than 97% as determined by SDS-PAGE.
Activity
96% of PCR product digestion after 30 minutes at 37°C. The reaction is performed as follow; 20µl reaction, including 100nM Cas9 protein, 200nM tracrRNA, 200nM EMX1-specific crRNA, 200ng EMX1-specific PCR product and 1x digestion buffer (20mM HEPES, 100mM NaCl and 5mM MgCl2, pH 6.5). Incubate 30 minutes at 37°C, and stop reaction with 1µl RNAse A (1mg/ml).
Storage condition: -20°C
10X Cas9 Reaction Buffer:
200 mM HEPES, 50 mM MgCl2, 1 M NaCl, 1 mM EDTA, pH 6.5
Storage Buffer:
50 mM Tris-HCl, 50 M KCl, 1 mM DTT, 1 mM EDTA, 50% Glycerol, pH 7.5
Name |
Cat# |
Size |
c |
Cas9 Nuclease (wt) |
CAS9-100 |
250 pmol, 50 µl |
5 µM |
Cas9 Nuclease (wt) |
CAS9-200 |
1 nmol, 50 µl |
20 µM |
Cas9 Nuclease NLS |
CAS9N-100 |
250 pmol, 50 µl |
5 µM |
Cas9 Nuclease NLS |
CAS9N-200 |
1 nmol, 50 µl |
20 µM |
Cas9 Nuclease 3NLS |
CAS9N3-100 |
250 pmol, 50 µl |
5 µM |
Cas9 Nuclease 3NLS |
CAS9N3-200 |
1 nmol, 50 µl |
20 µM |
Nickase Cas9 3NLS |
NICKASE-100 |
250 pmol, 50 µl |
5 µM |
Nickase Cas9 3NLS |
NICKASE-200 |
1 nmol, 50 µl |
20 µM |
dCas9 3NLS |
dCAS9-100 |
250 pmol, 50 µl |
5 µM |
dCas9 3NLS |
dCAS9-200 |
1 nmol, 50 µl |
20 µM |
Hi-Fi1 Cas9 3NLS (K848A, K1003A, R1060A) |
HF1CAS9-100 |
250 pmol, 50 µl |
5 µM |
Hi-Fi1 Cas9 3NLS (K848A, K1003A, R1060A) |
HF1CAS9-200 |
1 nmol, 50 µl |
20 µM |
Hi-Fi2 Cas9 3NLS (N497A, R661A, Q695A, Q926A) |
HF2CAS9-100 |
250 pmol, 50 µl |
5 µM |
Hi-Fi2 Cas9 3NLS (N497A, R661A, Q695A, Q926A) |
HF2CAS9-200 |
1 nmol, 50 µl |
20 µM |
dCas9-biotinylated 3NLS |
dCAS9B-100 |
250 pmol, 50 µl |
5 µM |
dCas9-biotinylated 3NLS |
dCAS9B-200 |
1 nmol, 50 µl |
20 µM |